Back to top

Analyst Blog

Shares of Rite Aid Corporation (RAD - Analyst Report) escalated 2.2% on the recent news of an expansion of its distribution agreement with McKesson Corporation (MCK - Analyst Report) for both brand and generic pharmaceuticals. Additionally, Rite Aid hit a 52-week high of $6.55 yesterday, before eventually closing at $6.41 and amassing a significantly high return over the past one year.

As per the terms of the expanded agreement, McKesson will be responsible for sourcing and distribution of generic pharmaceuticals for Rite Aid as a part of its proprietary One Stop Generics program. On the other hand, Rite Aid stores will benefit from McKesson’s daily direct-to-store delivery service model for brand and generic pharmaceutical products.

Rite Aid is one of the leading national drugstore chains in the U.S. while McKesson is a pioneer in pharmaceutical sourcing and supply chain management. This agreement, spanning for five years up to Mar 2019, will allow both the companies to leverage each other’s expertise.

Furthermore, shares of this Zacks Rank #3 (Hold) company have been gaining momentum since it posted positive 0.3% same-store sales (comps) for the four weeks ended Jan 26, 2013. The rise was an outcome of an increase in front-end comps, offset by a decline in pharmacy comps. Shares have jumped nearly 13.1% since the comps results released on Jan 30, 2014.

Rite Aid’s comps came as a relief for investors following the disappointing third-quarter fiscal 2014 results and an unfavorable outlook released in Dec 2013.

Looking ahead, the company’s sustained focus on expanding pharmacy and clinical services through its Wellness+ customer loyalty program and remodeling of wellness stores raise our hopes. We believe that such measures will enable the company to broaden its customer base and boost top- and bottom-line performance.

Currently, Rite Aid  trades at a forward P/E of 30.8x, a 64.1% premium to the peer group average of 18.77x. The last traded price is 2.4% above the Zacks Consensus average analyst price target of $6.26. Average volume of shares traded over the last 3 months stands at approximately 26,504K. Moreover, the company’s long-term EPS growth rate is 17.5%, ahead of the peer group average of 16.8%.

Other than Rite Aid, CBS Corporation (CBS - Analyst Report) and Lexmark International Inc. (LXK - Analyst Report) also reached highs of $66.58 and $42.34, respectively, on Feb 19, 2014.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ALASKA AIR… ALK 96.79 +2.26%
PILGRIMS PR… PPC 29.50 +1.90%
SASOL LTD -… SSL 58.83 +1.78%
NSK LTD -UN… NPSKY 26.70 +1.52%
CTPARTNERS… CTP 10.99 +1.29%